2024

Experienced Life Sciences Executive to Support Cosmeceuticals and Injectables Growth for New CDMO Business Unit Vancouver, British Columbia and Rehovot, Israel – March 21, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced the appointment of experienced life sciences executive

Management Adding Critical Leadership Roles to Support Growth of Recently Launched CDMO Business Unit Vancouver, British Columbia and Rehovot, Israel – March 13, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced the appointment of two senior hires in the

Vancouver, British Columbia and Rehovot, Israel – March 7, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology process, today announced that it has been invited to present at the iAccess Alpha Buyside Best Ideas Investor Conference on March 12-13, 2024. CEO Ilan

Vancouver, British Columbia and Rehovot, Israel – February 29, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced that it will host a corporate update webinar on Wednesday, March 13th to discuss the Company’s Contract Development and Manufacturing Organization (“CDMO”)